See how Dr. Belleannée addressed contamination concerns in her laboratoryThe BioFlux system is a game-changer in the world of experimental research. By employing a multiplexed array format, it revolutionizes the way flow cell experiments are conducted. Just picture this: a single 48-well plate has the potential to run an impressive 24 assays concurrently. And with the introduction of the Quattro add-on, a staggering 96 experiments can run in parallel. This substantial boost in data throughput means researchers can delve into more conditions, test hypotheses, and uncover drug pharmacology faster than ever before. But as we'll learn in this case study, the real-world benefits go far beyond multiplexing.
Fluxion is a California-based company that develops products such as liquid biopsy systems and cellular analysis tools for drug discovery and diagnostic applications.